- Home
- HG vs AORT Comparison
HG vs AORT Comparison
Compare HG & AORT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HG
- AORT
- Stock Information
- Founded
- HG 2013
- AORT 1984
- Country
- HG Bermuda
- AORT United States
- Employees
- HG N/A
- AORT N/A
- Industry
- HG
- AORT Medical/Dental Instruments
- Sector
- HG
- AORT Health Care
- Exchange
- HG Nasdaq
- AORT Nasdaq
- Market Cap
- HG 2.4B
- AORT 1.9B
- IPO Year
- HG 2023
- AORT 1993
- Fundamental
- Price
- HG $23.78
- AORT $42.06
- Analyst Decision
- HG Buy
- AORT Strong Buy
- Analyst Count
- HG 7
- AORT 6
- Target Price
- HG $27.29
- AORT $43.97
- AVG Volume (30 Days)
- HG 340.1K
- AORT 316.4K
- Earning Date
- HG 11-04-2025
- AORT 11-06-2025
- Dividend Yield
- HG N/A
- AORT N/A
- EPS Growth
- HG N/A
- AORT N/A
- EPS
- HG 3.61
- AORT N/A
- Revenue
- HG $2,599,247,000.00
- AORT $405,037,000.00
- Revenue This Year
- HG $21.94
- AORT $14.99
- Revenue Next Year
- HG $2.99
- AORT $10.80
- P/E Ratio
- HG $6.52
- AORT N/A
- Revenue Growth
- HG 21.31
- AORT 7.44
- 52 Week Low
- HG $16.80
- AORT $21.97
- 52 Week High
- HG $25.37
- AORT $45.07
- Technical
- Relative Strength Index (RSI)
- HG 46.00
- AORT 57.35
- Support Level
- HG $23.79
- AORT $39.41
- Resistance Level
- HG $24.69
- AORT $42.42
- Average True Range (ATR)
- HG 0.64
- AORT 1.12
- MACD
- HG -0.14
- AORT 0.02
- Stochastic Oscillator
- HG 22.55
- AORT 83.06
About HG Hamilton Insurance Group Ltd. Class B
Hamilton Insurance Group Ltd is a specialty insurance and reinsurance company. It operates globally, with underwriting operations in London, Dublin, Bermuda, and the United States. It operates three principal underwriting platforms (Hamilton Global Specialty, Hamilton Select and Hamilton Re) that are categorized into two reporting business segments: International and Bermuda.
About AORT Artivion Inc.
Artivion Inc offers cardiac and vascular surgeons a suite of aortic-centric solutions. The company's products include Aortic Heart Valve, Mitral Heart Valve, Aortic Allograft, Pulmonary Human Heart Valve, Pulmonary Patch, and Surgical Adhesive among others. The company's has two reportable segments: Medical Devices and Preservation Services. The Medical Devices segment includes revenues from sales of aortic stent grafts, surgical sealants, On-X products, and other product revenues. The Preservation Services segment includes services revenues from the preservation of cardiac and vascular implantable human tissues. Company operates in North America, EMEA. LATAM, APAC. Maximum revenue is from North America.